Wells Fargo maintains Inspire Medical Systems at Equal-Weight, raises price target to $69 from $56
Wells Fargo raised its price target for Inspire Medical Systems to $69 from $56, maintaining an Equal-Weight rating. The new target implies a 2.7% upside from the last close. Recent analyst price targets range from $60 to $78.
How this was made

The 30-second read
Why it matters
A higher target can attract incremental buyers and reduce downside expectations, but unchanged rating suggests limited urgency and likely smaller price follow-through than an upgrade.
Market read
Traders may use the target raise as a sentiment input, but it is not a standalone fundamental catalyst.
What to watch
The article does not include the thesis behind the target change, so traders may discount the move if it is driven by broad model assumptions rather than new company-specific fundamentals.
Background
The piece is an analyst note update: Wells Fargo keeps Inspire Medical Systems at Equal-Weight while increasing its price target.
Ticker impact
Wells Fargo maintained Inspire Medical Systems at Equal-Weight and raised its price target to $69 from $56, implying modest upside from the Nov 2 close.
Likely mild upward bias as traders price in the higher target, with upside capped by the unchanged Equal-Weight stance.
The article provides a specific, time-relevant price target change and an implied upside versus the prior close, but it is not a fundamental company event (no earnings, trial, or deal).
Market effects
Limited read-through to the broader medical device space because this is a single-name analyst target change without new clinical or regulatory data.
Minimal, as the catalyst is company-specific and not a macro release.
Low, since the update is tied to a US-listed equity and does not reference global policy or cross-border events.
Counterpoint
Because the rating stays Equal-Weight, the market may treat the target raise as incremental and focus instead on upcoming company catalysts (earnings, procedure demand, or trial/regulatory milestones).
Key entities
- companyInspire Medical Systems
Subject of the analyst action, with Wells Fargo raising its price target while maintaining Equal-Weight.
- analyst_firmWells Fargo
The brokerage issuing the maintained rating and revised price target.



